AMPPLIFY Trademark

Trademark Overview

On Monday, August 6, 2018, a trademark application was filed for AMPPLIFY with the United States Patent and Trademark Office. The USPTO has given the AMPPLIFY trademark a serial number of 88066300. The federal status of this trademark filing is REGISTERED as of Tuesday, December 31, 2019. This trademark is owned by Kala Pharmaceuticals, Inc.. The AMPPLIFY trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical products, namely, a drug delivery system comprising mucus-penetrating nanoparticles

Pharmaceutical products, namely, drug delivery agents in the form of sterile preserved ophthalmic suspension comprising mucus-penetrating nanoparticles
ampplify

General Information

Serial Number88066300
Word MarkAMPPLIFY
Filing DateMonday, August 6, 2018
Status700 - REGISTERED
Status DateTuesday, December 31, 2019
Registration Number5951075
Registration DateTuesday, December 31, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2019

Trademark Statements

Goods and ServicesPharmaceutical products, namely, a drug delivery system comprising mucus-penetrating nanoparticles
Goods and ServicesPharmaceutical products, namely, drug delivery agents in the form of sterile preserved ophthalmic suspension comprising mucus-penetrating nanoparticles

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 10, 2018
Primary Code005
First Use Anywhere DateTuesday, January 8, 2019
First Use In Commerce DateTuesday, January 8, 2019
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, March 21, 2019
Primary Code010
First Use Anywhere DateTuesday, January 8, 2019
First Use In Commerce DateTuesday, January 8, 2019

Trademark Owner History

Party NameALCON INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressFRIBOURG 1701
CH
Party NameKala Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameKala Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameKala Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Thursday, August 9, 2018NEW APPLICATION ENTERED
Friday, August 10, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 19, 2018ASSIGNED TO EXAMINER
Friday, October 19, 2018NON-FINAL ACTION WRITTEN
Friday, October 19, 2018NON-FINAL ACTION E-MAILED
Friday, October 19, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 21, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 21, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 21, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, April 14, 2019ASSIGNED TO LIE
Monday, April 22, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 22, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 1, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2019PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 7, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, October 24, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 7, 2019USE AMENDMENT FILED
Thursday, October 24, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, November 25, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 26, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 31, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, May 19, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, August 10, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, November 2, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, December 5, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 5, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 9, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 9, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 31, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 7, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, November 21, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 21, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 21, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

ampplify pharmaceutical penetrating nanoparticles comprising mucus products drug namely delivery ophthalmic